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ABSTRACT
Objective The present study aimed to determine whether 
the suicide risk increased after a cancer diagnosis.
Design Population- based cohort study.
Setting and participants This study incorporated the 
National Health Insurance Service- National Sample Cohort 
in South Korea. Of the 975 348 subjects, 39 027 with 
cancer and 936 321 who were cancer free participated 
between 2005 and 2013.
Primary outcome measure Suicide.
Results A total of 110 suicides (82 men, 28 women) were 
identified among these 39 027 subjects with cancer during 
a total of 127 184 person- years; among the 936 321 
cancer- free subjects, 2163 suicides were reported during 
a total of 8 222 479 person- years. Cox proportional hazards 
models were used to compare all- cause and suicide 
mortalities after cancer diagnosis following adjustment 
for possible confounding covariates. After adjusting 
for factors related to suicide, we identified an elevated 
relative risk of suicide among patients with cancer (HR: 
1.480, 95% CI: 1.209 to 1.812). Among men, the relative 
risk was substantially increased among patients with lip, 
oral cavity/pharyngeal, colon and rectal, pancreatic and 
lung cancers when compared with cancer- free subjects; 
whereas among women, the relative risk was substantially 
increased among patients with colon and rectal cancers.
Conclusion Our study observed an increased risk of 
suicide among patients with cancer that varied according 
to the anatomical cancer site, even after accounting for 
clinical comorbidities and psychiatric illness. Our findings 
indicate a need for social support and suicide prevention 
strategies for patients with cancer.
INTRODUCTION
Suicide is considered a major public health 
challenge and is among the leading global 
causes of a loss of life years.1 Notably, South 
Korea has the highest suicide rate among 
member nations of the Organization for 
Economic Co- operation and Development.2 
Suicide rates have continued to increase in 
South Korea throughout the past two decades 
with a peak in 2010, leading to the current 
designation of suicide as the fourth leading 
cause of death nationwide.3
A cancer diagnosis is a stressful and life- 
threatening event that causes considerable 
physical and psychological suffering.4 5 The 
associated distress might not only worsen 
the quality of life6 and accelerate disease 
progression,7 but may also promote non- 
cancer mortality.8 9 Patients with cancer, 
particularly, have a higher risk of suicide 
relative to that of the general population, 
and this risk may increase by up to twofold in 
many countries.10–16 A large body of evidence 
has identified many factors related to suicide 
among patients with cancer, including partic-
ular clinical characteristics, age at diagnosis, 
prognosis, stage, time since diagnosis, psychi-
atric health, and sociodemographic factors 
such as sex, race, and marital status.17 Previous 
studies also have found that the incidence of 
suicide is relatively high among patients with 
pancreatic,10 18 19 lung,10 12 13 19 20 colon and 
rectal,13 21 oral cavity/pharyngeal,12 13 18 laryn-
geal,13 stomach12 19 and cervical cancer.21
Despite the accumulation of evidence in 
support of an association between cancer 
and suicide, several studies have calculated 
the standardised mortality ratios (SMRs) to 
compare the suicide rate between patients 
with cancer and the general population 
while only evaluating differences in sociode-
mographic and clinical characteristics.12 13 16 
Strengths and limitations of this study
 ► The strengths of this study included the population- 
based design and acquisition of data from the 
National Health Insurance Service- National Sample 
Cohort, which is representative of the entire Korean 
population.
 ► This study featured a robust follow- up resulting 
from the use of unique personal identification num-
bers for Korean residents, which were linked to the 
national mortality database.
 ► We were unable to examine the risk factors associ-
ated with specific cancer types because of the small 
number of suicides in each specific cancer group.
 ► We were unable to identify some potential risk fac-
tors known to have important influences on suicide 
among patients with cancer.
 ► The use of administrative claims data is associat-
ed with a reliance on International Classification of 
Diseases-10 codes to determine comorbidity could 
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Additionally, previous studies have been limited by a failure 
to adjust for underlying psychiatric conditions,10 12 13 16 
even though pre- existing psychiatric conditions might 
modify the impact of a cancer diagnosis on the risk of 
suicide,22 particularly as cancer itself has been identified 
as a suicide risk factor when coupled with comorbidities 
such as psychiatric disease. Therefore, we investigated 
whether the suicide rate is higher among Korean patients 
with cancer than among the general population after 
controlling for underlying diseases including psychi-
atric disorders as well as sociodemographic and clinical 
characteristics. We further compared the risk of suicide 
according to the anatomical site of cancer with the risk 
observed in the general population.
METHODS AND MATERIALS
Data sources
As described in detail previously,23 data were acquired 
from the National Health Insurance Service- National 
Sample Cohort (NHIS- NSC) from 2002 to 2013 and 
included 1 025 340 representative subjects (2.2% of the 
population) who were randomly stratified and selected 
based on age, sex, insurance type, income, residential 
region and individual total medical costs at 2002. As all 
Korean citizens are obligated to enrol in the single- payer, 
national health insurance and medical aid programme 
administered by the National Health Insurance Corpora-
tion, this sample cohort is representative of the general 
Korean population. The NHIS- NSC database includes 
information regarding patients’ unique de- identification 
numbers, age, sex, insurance type, diagnosis according 
to the International Classification of Diseases (ICD-10), 
medical costs and prescribed drugs. In addition, these 
numbers are linked to mortality information from the 
Korean National Statistical Office (KNSO). By law, all 
causes of death must be reported to the KNSO within 
1 month of occurrence. Details of the NHIS- NSC database 
have been provided in a previous report.24
Study participants and follow-up
Of the 1 025 340 subjects, we eliminated 17 297 patients 
who had been diagnosed with cancer between 2002 and 
2004, thus ensuring the selection of cancer- free subjects 
at baseline. We additionally eliminated 32 695 subjects 
for whom information was missing due to a follow- up 
loss (death, emigration or disqualification from national 
health insurance) between 2002 and 2004. Overall, this 
study included 975 348 subjects (online supplemental 
figure 1).
Outcome and follow-up
The outcome variables for this study were all- cause 
mortality and suicide (ICD-10 code X64–80). All subjects 
were observed from 1 January 2005 to follow- up loss, 
death (by suicide or any other cause) or 31 December 
2013, whichever occurred first. For subjects who did not 
develop cancer, follow- up ended on the date of suicide, 
other death, emigration or 31 December 2013, whichever 
occurred first; accumulated person- time was defined as 
the unexposed person- time. For those who were diag-
nosed with cancer, the follow- up ended with the occur-
rence of suicide, other death, emigration out of Korea 
or 31 December 2013, whichever came first; accumulated 
person- time was defined as the exposed person- time. 
Participants diagnosed with cancer during the study 
period contributed unexposed person- time prior to the 
date of diagnosis (as recorded in the national health 
insurance data) and exposed person- time thereafter.
Cancer diagnosis
Cancer diagnoses were organised into 13 diagnostic 
groups: lip, oral cavity and pharynx (ICD-10 codes C00, 
C11, C12, C13, C14); stomach (C16); colon and rectum 
(C17, C18, C19, C20, C21); liver (C22); gallbladder and 
pancreas (C23, C24, C25); lung (C33, C34); breast (C50); 
gynaecological (cervix, uterus and ovary: C53, C54, C56); 
prostate (C61); testis and other male genital organs (C62); 
bladder (C67); thyroid (C73); and others (oesophagus: 
C15; larynx: C32; skin: C43, C44; kidney: C64, C65, C66, 
C68; brain and central nervous system: C70, C71, C72; 
Hodgkin’s lymphoma: C81; non- Hodgkin’s lymphoma: 
C82, C83, C84, C85, C96; leukaemia: C91, C92, C93, C94, 
C95).
Covariates
Sociodemographic and clinical risk factors for suicide 
were included in this study. Sociodemographic factors 
recorded on the date of entry into the study included 
sex, age (≤39, 40–49, 50–59, 60–69 and ≥70 years), 
region (urban or rural) and household income (income 
quintiles Q1 (low) to Q5 (high)). We used the average 
monthly insurance premium as a proxy for household 
income. In Korea, individuals qualify for medical aid if 
their household income is less than $600 per month; 
otherwise, they qualify for national health insurance. 
Individuals enrolled in the national health insurance 
programme were distributed between the 1st and 100th 
income percentiles, whereas those receiving medical aid 
were classified at the zero percentile. In this study, the 
following household income classification was used: Q1, 
<20%; Q2, 21%–40%; Q3, 41%–60%; Q4, 61%–80% and 
Q5, >80%. We also included the experience of at least 
one disability (according to the disabled person welfare 
law), including intellectual disability, brain lesion, deaf-
ness, physical disability, visual impairment, mental 
disorder, kidney disorder, language disorder, autism, 
heart disability, respiratory disorder, hepatopathy, facial 
disorders, having undergone ostomy and epilepsy.
Regarding clinical factors, patients’ comorbidities were 
identified via review of their medical histories 12 months 
prior to study entry. Using the Charlson Comorbidity 
Index, we measured 17 comorbidities to control for the 
case mix.25 Additionally, underlying diagnoses related 
to psychiatric disorders included substance abuse (F10–
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(F31), major depressive disorder (F32–F33), anxiety and 
stress disorders (F40–F48), sleep disorders (F51, G47) 
and personality disorders (F6).
Statistical analysis
For this study, we determined the distributions of general 
characteristics by diagnosis of cancer. Additionally, rela-
tionships between household income level and suicide 
were analysed using time- to- event methods. The Kaplan- 
Meier method was used to generate curves of unadjusted 
mortality rates, which were compared using the log- rank 
test. To determine whether the suicide rate was higher 
among patients with cancer relative to the general popu-
lation, multivariable analyses involving Cox proportional 
hazards models were conducted to calculate adjusted HRs 
plus 95% CIs as estimates of relative suicide rates. The 
proportionality assumption was tested by examining log 
curves (−log (survivor function)) versus time. A p value 
of <0.05 was considered to indicate statistical significance. 
All statistical analyses were conducted using the SAS soft-
ware package (V.9.4; SAS Institute).
Patient and public involvement
Patients and the public were not involved in the design or 
planning of this study.
RESULTS
Table 1 presents the general characteristics of the study 
participants. Of the 975 348 subjects, 39 027 (4.0%) 
received a diagnosis of cancer between 2005 and 2013, 
and a total of 110 suicides (82 men, 28 women) were iden-
tified among these subjects with cancer during a total of 
127 184 person- years. Of the 936 321 cancer- free subjects 
with a total of 8 222 479 person- years, 2163 died by suicide 
during the study period. The suicide rate was 86 per 
100.000 person- years in those with cancer compared with 
26 in those without cancer. Using Kaplan- Meier survival 
curves of the unadjusted cumulative suicide rates among 
patients with cancer and cancer- free subjects (figure 1), a 
significantly higher risk of suicide was identified among 
the cancer group (log- rank, p<0.001).
Table 2 presents the results of a Cox proportional 
hazards analysis of the association between cancer diag-
nosis and suicide risk. Even after adjusting for factors 
related to suicide among patients with cancer, we 
observed an elevated relative risk of suicide (HR: 1.480, 
95% CI: 1.209 to 1.812). Notably, the relative suicide risk 
was significantly more elevated among male subjects (HR: 
1.513, 95% CI: 1.191 to 1.922), compared with female 
subjects (HR: 1.320, 95% CI: 0.895 to 1.947). Higher 
suicide rates were found to associate with male sex, 
older age, lower income, presence of a disability, higher 
Charlson Comorbidity Index and presence of psychiatric 
illness.
Figures 2–4 present the adjusted risks of suicide 
according to anatomical cancer site in both male and 
female subjects. Among men, the relative risk was 
increased substantially for patients with lip, oral cavity and 
pharyngeal (HR: 1.987, 95% CI: 1.025 to 3.853), colon 
and rectal (HR: 1.906; 95% CI: 1.174 to 3.093), pancreatic 
(HR: 3.777; 95% CI: 1.211 to 11.784) and lung cancers 
(HR: 2.502; 95% CI: 1.463 to 4.280), compared with the 
cancer- free group. Among women, the relative risk was 
substantially increased for patients with colon and rectal 
cancers (HR: 2.376, 95% CI: 1.120 to 5.041).
DISCUSSION
Summary
In this population- based cohort study, we used data from 
the NHIS- NSC to investigate whether the risk of suicide 
was higher among patients with cancer than among 
the general population. We found that the suicide risk 
was indeed higher among those diagnosed with cancer 
during the study period, and that the risk of suicide 
varied according to the anatomical cancer site, as men 
diagnosed with lip, oral cavity and pharyngeal, colon and 
rectal, liver, pancreatic and lung cancers and women diag-
nosed with colon and rectal cancers had a significantly 
higher risk of suicide relative to the general population.
Comparison with studies
Our findings were consistent with those of other studies 
that examined the relationship between cancer diag-
nosis and suicide, in which the incidence rates of suicide 
among male and female patients with cancer were, 
respectively, 1.5 and 1.3 times higher than the rates in the 
general population after adjusting for factors associated 
with suicide. Similarly, in the USA, the suicide risk among 
patients with cancer is approximately twofold of the risk 
in the general population,13 and European studies have 
also observed increased suicide rates among patients with 
cancer. For example, Yousaf et al14 calculated SMRs of 1.7 
and 1.4 for suicide among men and women, respectively, 
from a Danish cancer registry relative to the general 
Danish population. A similar study in Norway reported 
SMRs of 1.55 and 1.35.12 In Sweden, Björkenstam et al11 
observed SMRs of 2.5 (men and women combined) for 
the period from 1965 to 1974 and 1.5 for the period from 
Figure 1 Cumulative suicide rates of patients with cancer 
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1985 to 1994. In Asia, a Korean study used cancer registry 
data to calculate SMRs of 2.05 among male patients and 
1.87 among female patients for the period from 1993 to 
2005.10
Several studies have found associations of cancers at 
certain anatomical sites with particularly elevated suicide 
rates. However, reports differ with regard to the anatom-
ical sites associated with the greatest suicide risks.11–14 16 In 
our study of patients in Korea, we found that the suicide 
risks were especially high among male patients with lip, 
oral cavity and pharyngeal, colon and rectal, liver, pancre-
atic, and lung cancers and among female patients with 
colon and rectal cancer, findings that were concordant 
with reports from Western countries.11–13 26 Although 
the reasons underlying the associations of particular 
cancer types with increased suicide rates are unknown, 
patients with those cancers might struggle with grave 
prognoses.8 14 16 This is corroborated by a finding that the 
suicide risk was higher among patients with cancers that 
conferred a poor prognosis (ie, 5- year relative survival 
of <10%), especially within the first year of diagnosis. 
Additionally, certain types of cancers, especially head and 
neck cancers, might have more profound effects on the 
quality of life and induce stronger degrees of anxiety or 
fear because of symbolic values, changes in appearance, 
or difficulties with speech, swallowing, and breathing.27 
One study identified a 25% prevalence of depression 
among patients with lung cancer,28 and another study 
suggested that the lower quality of life among patients 
with lung cancer is related to emotional distress.29 Simi-
larly, a high prevalence of depression has been observed 






































































































































































































































































































































































































Figure 2 Adjusted risks of suicide by cancer type (all 
participants).
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Strengths and limitations
The strengths of this study included the population- based 
design and acquisition of data from the NHIS- NSC, which 
is representative of the entire Korean population. In 
addition, this study featured a robust follow- up resulting 
from the use of unique personal identification numbers 
for Korean residents, which were linked to the national 
mortality database. Despite these strengths, our find-
ings should be interpreted in light of the study’s limita-
tions. First, we were unable to examine the risk factors 
associated with specific cancer types because of the 
small number of suicides in each specific cancer group. 
Further study needs to examine the relationship between 
cancer and suicide according to cancer stage and cancer 
type by linking cancer registration data and claims data 
(not sample data) of all citizens. Second, as with other 
studies that employ administrative claims data,23 we were 
unable to identify some potential risk factors known to 
have important influences on suicide among patients 
with cancer, such as the family history of suicide attempts, 
history of suicide attempts and patients’ histories of self- 
harm, which were unknown. Third, the use of adminis-
trative claims data is associated with particular issues. 
For example, a reliance on ICD-10 codes to determine 
comorbidity could lead to misclassification consequent 
to miscoding behaviours. Fourth, an inaccuracy on the 
ICD-10 codes for the diagnoses might have yielded some 
misclassifications due to the unavoidable characteristics 
of claims data, including miscoding of data by the orig-
inal coder. Fifth, given the retrospective nature of this 
chart review study, we could not evaluate psychiatric 
symptoms after a cancer diagnosis, which are known 
to have an important influence on suicidal behaviours 
among patients with cancer, despite the availability of 
information regarding the history of psychiatric care. 
Sixth, our limited data set did not permit consideration of 
the influence of disease stage at diagnosis in our suicide 
risk analysis.
CONCLUSION
In our study of a cohort representative of the Korean 
population, patients with cancer were found to exhibit 
an increased risk of suicide, which varied according to 
the anatomical cancer site even after accounting for clin-
ical comorbidities and psychiatric illness. These results 
provide further evidence of a relationship between cancer 
diagnosis and suicide. Further research into the suicide 
risks of patients with cancer should extend the range of 
concerns to include disease stage and clinical treatment.
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